Agenus Inc - Net Worth and Insider Trading
Agenus Inc Net Worth
The estimated net worth of Agenus Inc is at least $22 Million dollars as of 2024-05-21. Agenus Inc is the 10% Owner of MiNK Therapeutics Inc and owns about 21,772,863 shares of MiNK Therapeutics Inc (INKT) stock worth over $22 Million. Details can be seen in Agenus Inc's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Agenus Inc has not made any transactions after 2023-10-16 and currently still holds the listed stock(s).
Transaction Summary of Agenus Inc
Agenus Inc Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Agenus Inc owns 1 companies in total, including MiNK Therapeutics Inc (INKT) .
Click here to see the complete history of Agenus Inc’s form 4 insider trades.
Insider Ownership Summary of Agenus Inc
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
INKT | MiNK Therapeutics Inc | 2023-10-16 | 10 percent owner |
Agenus Inc Latest Holdings Summary
Agenus Inc currently owns a total of 1 stock. Agenus Inc owns 21,772,863 shares of MiNK Therapeutics Inc (INKT) as of October 16, 2023, with a value of $22 Million.
Latest Holdings of Agenus Inc
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
INKT | MiNK Therapeutics Inc | 2023-10-16 | 21,772,863 | 0.99 | 21,555,134 |
Holding Weightings of Agenus Inc
Agenus Inc Form 4 Trading Tracker
According to the SEC Form 4 filings, Agenus Inc has made a total of 7 transactions in MiNK Therapeutics Inc (INKT) over the past 5 years, including 7 buys and 0 sells. The most-recent trade in MiNK Therapeutics Inc is the acquisition of 22,975 shares on October 16, 2023, which cost Agenus Inc around $25,273.
Insider Trading History of Agenus Inc
- 1
Agenus Inc Trading Performance
GuruFocus tracks the stock performance after each of Agenus Inc's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Agenus Inc is -19.33%. GuruFocus also compares Agenus Inc's trading performance to market benchmark return within the same time period. The performance of stocks bought by Agenus Inc within 3 months outperforms 2 times out of 7 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Agenus Inc's insider trading performs compared to the benchmark.
Agenus Inc Ownership Network
Ownership Network List of Agenus Inc
Ownership Network Relation of Agenus Inc
Agenus Inc Owned Company Details
What does MiNK Therapeutics Inc do?
Who are the key executives at MiNK Therapeutics Inc?
Agenus Inc is the 10 percent owner of MiNK Therapeutics Inc. Other key executives at MiNK Therapeutics Inc include Treasurer Christine M Klaskin , director & See Remarks Jennifer Buell , and Chief Technology Officer Van Dijk Marcus Antonius .
MiNK Therapeutics Inc (INKT) Insider Trades Summary
Over the past 18 months, Agenus Inc made 6 insider transaction in MiNK Therapeutics Inc (INKT) with a net purchase of 546,494. Other recent insider transactions involving MiNK Therapeutics Inc (INKT) include a net sale of 0 shares made by Garo H Armen ,
In summary, during the past 3 months, insiders sold 0 shares of MiNK Therapeutics Inc (INKT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 100,000 shares of MiNK Therapeutics Inc (INKT) were sold and 646,494 shares were bought by its insiders, resulting in a net purchase of 546,494 shares.
MiNK Therapeutics Inc (INKT)'s detailed insider trading history can be found in Insider Trading Tracker table.
MiNK Therapeutics Inc Insider Transactions
Agenus Inc Mailing Address
Above is the net worth, insider trading, and ownership report for Agenus Inc. You might contact Agenus Inc via mailing address: 3 Forbes Road, Lexington Ma 02421.